Steven B Uittenbogaart
About
In The Last Decade
Steven B Uittenbogaart
9 papers receiving 128 citations
Peers
Comparison fields: 5 of 17
- Cardiology and Cardiovascular Medicine 126
- Epidemiology 16
- Economics and Econometrics 11
- Radiology, Nuclear Medicine and Imaging 10
- Surgery 8
Countries citing papers authored by Steven B Uittenbogaart
This map shows the geographic impact of Steven B Uittenbogaart's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Steven B Uittenbogaart with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Steven B Uittenbogaart more than expected).
Fields of papers citing papers by Steven B Uittenbogaart
This network shows the impact of papers produced by Steven B Uittenbogaart. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Steven B Uittenbogaart. The network helps show where Steven B Uittenbogaart may publish in the future.
Co-authorship network of co-authors of Steven B Uittenbogaart
This figure shows the co-authorship network connecting the top 25 collaborators of Steven B Uittenbogaart. A scholar is included among the top collaborators of Steven B Uittenbogaart based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Steven B Uittenbogaart. Steven B Uittenbogaart is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 4 | |
| 2 | 3 | |
| 3 | 6 | |
| 4 | 5 | |
| 5 | 52 | |
| 6 | [Elderly patients and atrial fibrillation: age alone should not be a contra-indication for anticoagulant treatment]. | 1 |
| 7 | 31 | |
| 8 | 24 | |
| 9 | [Mesalazine and sulphasalazine for Crohn's disease: few indications, severe adverse reactions]. | 2 |
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.